Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price
Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the NHS after negotiations over its cost proved successful.
About 1,000 women a year with HER2-low advanced breast cancer will be able to obtain Enhertu from Thursday after ministers and the drug’s makers struck a deal on its price.
The post Women in England with incurable breast cancer to get life-extending drug on NHS appeared first on World news | The Guardian.